BioRem Inc. (BRM) - Net Assets
Based on the latest financial reports, BioRem Inc. (BRM) has net assets worth CA$15.30 Million CAD (≈ $11.07 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$31.54 Million ≈ $22.82 Million USD) and total liabilities (CA$16.25 Million ≈ $11.75 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BRM tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$15.30 Million |
| % of Total Assets | 48.49% |
| Annual Growth Rate | N/A |
| 5-Year Change | 659.85% |
| 10-Year Change | 515.0% |
| Growth Volatility | 560.92 |
BioRem Inc. - Net Assets Trend (2003–2025)
This chart illustrates how BioRem Inc.'s net assets have evolved over time, based on quarterly financial data. See BioRem Inc. defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for BioRem Inc. (2003–2025)
The table below shows the annual net assets of BioRem Inc. from 2003 to 2025. For live valuation and market cap data, see BRM company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$14.93 Million ≈ $10.80 Million |
+40.48% |
| 2024-12-31 | CA$10.63 Million ≈ $7.69 Million |
+58.12% |
| 2023-12-31 | CA$6.72 Million ≈ $4.86 Million |
+48.65% |
| 2022-12-31 | CA$4.52 Million ≈ $3.27 Million |
+130.13% |
| 2021-12-31 | CA$1.96 Million ≈ $1.42 Million |
-85.48% |
| 2020-12-31 | CA$13.52 Million ≈ $9.78 Million |
+15.36% |
| 2019-12-31 | CA$11.72 Million ≈ $8.48 Million |
-9.08% |
| 2018-12-31 | CA$12.90 Million ≈ $9.33 Million |
+76.66% |
| 2017-12-31 | CA$7.30 Million ≈ $5.28 Million |
+200.76% |
| 2016-12-31 | CA$2.43 Million ≈ $1.76 Million |
+25.53% |
| 2015-12-31 | CA$1.93 Million ≈ $1.40 Million |
+849.13% |
| 2014-12-31 | CA$-258.09K ≈ $-186.70K |
-129.17% |
| 2013-12-31 | CA$884.72K ≈ $639.99K |
+1519.56% |
| 2012-12-31 | CA$54.63K ≈ $39.52K |
-91.32% |
| 2011-12-31 | CA$629.11K ≈ $455.09K |
-88.75% |
| 2010-12-31 | CA$5.59 Million ≈ $4.05 Million |
-34.58% |
| 2009-12-31 | CA$8.55 Million ≈ $6.18 Million |
-2.75% |
| 2008-12-31 | CA$8.79 Million ≈ $6.36 Million |
+3.18% |
| 2007-12-31 | CA$8.52 Million ≈ $6.16 Million |
-24.82% |
| 2006-12-31 | CA$11.33 Million ≈ $8.20 Million |
+31.23% |
| 2005-12-31 | CA$8.63 Million ≈ $6.25 Million |
+2145.27% |
| 2004-12-31 | CA$384.55K ≈ $278.18K |
+139.70% |
| 2003-12-31 | CA$-968.76K ≈ $-700.79K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BioRem Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 816930900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CA$5.86 Million | 39.25% |
| Other Components | CA$9.07 Million | 60.75% |
| Total Equity | CA$14.93 Million | 100.00% |
BioRem Inc. Competitors by Market Cap
The table below lists competitors of BioRem Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dimension Computer Technology Co Ltd
TWO:6140
|
$36.41 Million |
|
STRUCT.MONIT.SYSCDIS
F:RJP
|
$36.41 Million |
|
WESTBRIDGE RE. EN. CORP.
F:PUQ
|
$36.41 Million |
|
Adcorp
JSE:ADR
|
$36.42 Million |
|
Eternal Energy Public Company Limited
BK:EE
|
$36.39 Million |
|
TAEYANG Corporation
KQ:053620
|
$36.36 Million |
|
Ostim Endustriyel Yatirimlar ve Isletme AS
IS:OSTIM
|
$36.34 Million |
|
Relief Therapeutics Holding AG
SW:RLF
|
$36.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BioRem Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,625,083 to 14,925,784, a change of 4,300,701 (40.5%).
- Net income of 4,816,597 contributed positively to equity growth.
- Share repurchases of 100,140 reduced equity.
- New share issuances of 15,525 increased equity.
- Other factors decreased equity by 431,281.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$4.82 Million | +32.27% |
| Share Repurchases | CA$100.14K | -0.67% |
| Share Issuances | CA$15.53K | +0.1% |
| Other Changes | CA$-431.28K | -2.89% |
| Total Change | CA$- | 40.48% |
Book Value vs Market Value Analysis
This analysis compares BioRem Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.35x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | CA$-3.22 | CA$3.10 | x |
| 2004-12-31 | CA$0.90 | CA$3.10 | x |
| 2005-12-31 | CA$0.75 | CA$3.10 | x |
| 2006-12-31 | CA$1.03 | CA$3.10 | x |
| 2007-12-31 | CA$0.71 | CA$3.10 | x |
| 2008-12-31 | CA$0.81 | CA$3.10 | x |
| 2009-12-31 | CA$0.71 | CA$3.10 | x |
| 2010-12-31 | CA$0.46 | CA$3.10 | x |
| 2011-12-31 | CA$0.05 | CA$3.10 | x |
| 2012-12-31 | CA$0.00 | CA$3.10 | x |
| 2013-12-31 | CA$0.03 | CA$3.10 | x |
| 2014-12-31 | CA$-0.02 | CA$3.10 | x |
| 2015-12-31 | CA$0.06 | CA$3.10 | x |
| 2016-12-31 | CA$0.07 | CA$3.10 | x |
| 2017-12-31 | CA$0.19 | CA$3.10 | x |
| 2018-12-31 | CA$0.33 | CA$3.10 | x |
| 2019-12-31 | CA$0.30 | CA$3.10 | x |
| 2020-12-31 | CA$0.34 | CA$3.10 | x |
| 2021-12-31 | CA$0.05 | CA$3.10 | x |
| 2022-12-31 | CA$0.26 | CA$3.10 | x |
| 2023-12-31 | CA$0.39 | CA$3.10 | x |
| 2024-12-31 | CA$0.67 | CA$3.10 | x |
| 2025-12-31 | CA$0.93 | CA$3.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BioRem Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 32.27%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.37%
- • Asset Turnover: 1.26x
- • Equity Multiplier: 2.25x
- Recent ROE (32.27%) is above the historical average (-74.74%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 0.00% | 22.32% | 2.43x | 0.00x | CA$2.02 Million |
| 2004 | -6.56% | -1041.76% | 0.01x | 1.03x | CA$-63.68K |
| 2005 | 3.98% | 3.21% | 0.90x | 1.39x | CA$-519.54K |
| 2006 | -6.79% | -6.41% | 0.82x | 1.29x | CA$-1.90 Million |
| 2007 | -35.23% | -31.69% | 0.82x | 1.35x | CA$-3.85 Million |
| 2008 | -4.92% | -3.00% | 0.85x | 1.93x | CA$-1.31 Million |
| 2009 | -5.88% | -2.66% | 1.25x | 1.77x | CA$-1.36 Million |
| 2010 | -56.11% | -18.08% | 1.10x | 2.83x | CA$-3.70 Million |
| 2011 | -535.58% | -27.97% | 1.16x | 16.48x | CA$-3.43 Million |
| 2012 | -1519.38% | -5.38% | 1.58x | 179.04x | CA$-835.45K |
| 2013 | 81.11% | 3.66% | 2.20x | 10.07x | CA$629.15K |
| 2014 | 0.00% | -16.12% | 1.39x | 0.00x | CA$-1.70 Million |
| 2015 | 87.35% | 10.00% | 1.82x | 4.81x | CA$1.50 Million |
| 2016 | 22.55% | 3.44% | 1.40x | 4.67x | CA$304.58K |
| 2017 | 20.96% | 6.78% | 1.44x | 2.15x | CA$800.18K |
| 2018 | 36.18% | 19.17% | 1.16x | 1.63x | CA$3.38 Million |
| 2019 | -11.11% | -6.31% | 1.17x | 1.50x | CA$-2.47 Million |
| 2020 | 15.44% | 8.57% | 1.11x | 1.62x | CA$736.38K |
| 2021 | 66.05% | 5.30% | 1.28x | 9.76x | CA$1.10 Million |
| 2022 | 35.68% | 5.59% | 1.39x | 4.59x | CA$1.16 Million |
| 2023 | 32.43% | 8.66% | 1.05x | 3.58x | CA$1.51 Million |
| 2024 | 28.65% | 8.13% | 1.31x | 2.68x | CA$1.98 Million |
| 2025 | 32.27% | 11.37% | 1.26x | 2.25x | CA$3.32 Million |
Industry Comparison
This section compares BioRem Inc.'s net assets metrics with peer companies in the Pollution & Treatment Controls industry.
Industry Context
- Industry: Pollution & Treatment Controls
- Average net assets among peers: $1,864,329
- Average return on equity (ROE) among peers: -5.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BioRem Inc. (BRM) | CA$15.30 Million | 0.00% | 1.06x | $36.41 Million |
| Appulse Corp (APL) | $1.95 Million | -45.85% | 1.25x | $2.24 Million |
| Questor Technology Inc. (QST) | $2.67 Million | 44.79% | 0.31x | $4.92 Million |
| Sparta Capital Ltd (SAY) | $-502.81K | 0.00% | 0.00x | $3.61 Million |
| Thermal Energy International Inc. (TMG) | $3.89 Million | -10.89% | 2.35x | $19.17 Million |
| Current Water Technologies Inc (WATR) | $1.31 Million | -17.52% | 0.10x | $1.66 Million |
About BioRem Inc.
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It a… Read more